Shenfield_NIV Versus HFNC For Hypoxic Respiratory Failure

Access this class and others at A&T Respiratory Lectures This presentation is an essential component of the ongoing educational programs offered by A&T Respiratory Lectures. This comprehensive session provides respiratory therapists and healthcare practitioners with high-quality clinical insights and offers AARC-approved CEUs to support your continuing education and professional development. In this class, expert speaker Terrence Shenfield explores the critical clinical decisions surrounding patient management in the intensive care unit. The session provides an in-depth, evidence-based comparison of two widely utilized respiratory support modalities: non-invasive ventilation (NIV) and high-flow nasal cannula (HFNC). Designed specifically for clinicians managing complex cases, the video details how to navigate the technical settings, physiological effects, and oxygenation capabilities of each device. Practitioners will learn to identify the precise medical conditions in which one modality outperforms the other, specifically for acute de novo conditions and severe hypoxemia. The lecture reviews major clinical trials, including the FLORALI study, and underscores the risk factors associated with prolonged device usage. A key highlight of the course is the practical breakdown of the HACOR score, an objective scoring tool that evaluates heart rate, pH, Glasgow Coma Scale, PF ratio, and respiratory rate to predict treatment failure. By understanding these vital clinical metrics, healthcare providers can accurately time the transition to invasive mechanical ventilation, avoid self-inflicted lung injury, and ultimately reduce hospital mortality rates. #RespiratoryTherapy #NonInvasiveVentilation #HighFlowNasalCannula #RespiratoryFailure